Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.

BMC Cancer · 2017 · PMC5225543 · PMID 28077117

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Conclusions We verified a borderline significant association between increasing TOP1 CN and objective response as previously reported.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.